Avid Bioservices to Exhibit at the Bioprocessing Summit 2018
August 08 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that the company will
exhibit at the upcoming Bioprocessing Summit 2018. Avid will host a
corporate booth (#310) in the conference’s exhibit hall, where it
will showcase the company’s comprehensive range of process
development, high quality cGMP clinical and commercial
manufacturing services. The Bioprocessing Summit 2018 is being held
August 13-17, 2018 in Boston, MA.
As part of its exhibit at the Bioprocessing
Summit 2018, Avid will provide a virtual tour of the company’s
42,000 square foot state-of-the-art commercial biomanufacturing
suite (Myford facility), which is in the unique position of being a
validated facility with immediately available 2,000-liter scale
bioreactor capacity. The company will also discuss the ongoing
expansion of its process development capabilities and
laboratories.
The Myford facility, located in Tustin,
California, incorporates a variety of cutting-edge, single-use
equipment with the goal of ultimately accommodating a fully
disposable biomanufacturing process. A wide range of innovative
features are incorporated into the facility including monolithic
modular clean rooms, dedicated support utilities for each key
processing area, and the industry’s most advanced single-use
production systems and flexible solutions. Uni-directional process
flows separate personnel and materials and provide assurance that
the design meets the most stringent regulatory requirements for
commercial biologics drug substance manufacturing. This facility
complements Avid’s legacy commercial facility, located on the same
campus, which continues to be responsible for the manufacture of
multiple globally marketed commercial products.For more information
on the Bioprocessing Summit 2018, please visit:
http://www.bioprocessingsummit.com/
About Avid Bioservices,
Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and cGMP manufacturing of biopharmaceutical products
derived from mammalian cell culture. The company provides a
comprehensive range of process development, high quality cGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 25 years of
experience producing monoclonal antibodies and recombinant proteins
in batch, fed-batch and perfusion modes, Avid's services include
cGMP clinical and commercial product manufacturing, purification,
bulk packaging, stability testing and regulatory strategy,
submission and support. The company also provides a variety of
process development activities, including cell line development and
optimization, cell culture and feed optimization, analytical
methods development and product
characterization. www.avidbio.com
Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc.
(800) 987-8256
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2023 to Apr 2024